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Inflammation is an essential physiological response to infection and injury that must be kept within strict
bounds. The IL-10/STAT3 anti-inflammatory response (AIR) is indispensable for controlling the extent of
inflammation, although the complete mechanisms downstream of STAT3 have not yet been elucidated. The
AIR is widely known to extend to other myeloid cells, but it has best been characterized in macrophages. Here
we set out to characterize the LPS-mediated pro-inflammatory response and the AIR across a range of myeloid
cells. We found that whereas the LPS-induced pro-inflammatory response is broadly similar among
macrophages, dendritic cells, neutrophils, mast cells and eosinophils, the AIR is drastically different across all
myeloid cell types that respond to IL-10 (all bar eosinophils). We propose a model whereby the IL-10/STAT3
AIR works by selectively inhibiting specific pathways in distinct cell types: in macrophages the AIR most likely
works through the inhibition of NF-kB target genes; in DCs and mast cells through indirect IRF disruption;
and in neutrophils through IRF disruption and possibly also indirect NF-kB inhibition. In summary, no
conserved IL-10/STAT3 AIR effectors were identified; instead a cell type-specific model of the AIR is proposed.
I
nflammation is a crucial physiological response to infection and injury that must be rapidly and carefully
managed tomaintain the proper functioning of tissues with precise spatiotemporal control. Bacterial infection
is a classic model of inflammation, where lipopolysaccharide (LPS, a major outer membrane component of
Gram-negative bacteria) is an endotoxin that may eventually lead to sepsis, the uncontrolled release of pro-
inflammatory cytokines1. Toll-like receptor 4 (TLR4) is a central mediator of the innate and adaptive immune
responses to LPS and its activation ultimately results in cytokine production, among other cellular responses2.
Multiple pro- and anti-inflammatory molecules act to resolve and modulate the level of inflammation3,4, such
as IL-10, a crucial negative regulator of inflammation. This potent anti-inflammatory cytokine4–6 was originally
discovered as a critical factor produced by Th2 cells to suppress Th1 cell function7, but was later found to be
produced by a wide-range of immune cells (e.g. macrophages, dendritic cells, T cells, B cells, mast cells and
neutrophils) in response to inflammatory signals, and enacts a systemic anti-inflammatory response (AIR)8. The
signaling pathways that culminate in the production of IL-10 are complex and might be cell type-specific and
stimulus-dependent8,9.
The central role of IL-10 in deactivating immune cells in response to pathogenic invasion10,11 has been amply
demonstrated by the numerous ways that pathogens have evolved to hijack the IL-10/STAT3 signaling pathway
to prolong their survival. For example, Leishmania major and Mycobacterium tuberculosis both induce Il10
expression to activate an AIR through STAT312,13. Toxoplasma gondii’s ROP16 kinase phosphorylates STAT3
in macrophages to activate the AIR, thereby escaping inflammation14,15. Lymphocytic choriomeningitis virus
leads to increased levels of IL-10, poor clearance of the virus and defects in T cell responses16, and IL-10 plays a
similar role in HIV infection17. Fascinatingly, cytomegalovirus and Epstein-Barr virus harbor IL-10 orthologues
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in their genomes18,19. All these observations suggest that high IL-10
levels are important in establishing persistent infections11. Besides its
role in tempering excessive inflammation, IL-10 is essential for con-
trolling the extent of inflammation in the intestine: the Il10 knockout
mouse is the prototypical model of Crohn’s disease20, and mutations
in the human IL-10 receptor leads to severe inflammatory bowel
disease with raised levels of TNFa21.
Although best studied in macrophages, the IL-10/STAT3 anti-
inflammatory pathway has long been known to extend to other cells
of the myeloid system22. For instance a macrophage and neutrophil-
specific Stat3 knockout develops chronic enterocolitis23. In neutro-
phils, IL-10 has been implicated as a potent anti-inflammatory
factor24 that can down-regulate ROS production25. IL-10 can also
suppress TNFa and IL-6 production in rat mast cells26. In eosino-
phils, IL-10 treatment results in apoptosis and an AIR-like suppres-
sion of TNFa and IL-827. However, a detailed molecular description
of the mechanisms whereby IL-10 enacts the AIR in distinct myeloid
cell types is currently lacking and is of fundamental importance for
obtaining a global picture of how the various cells of the immune
system combat infection in a dynamic manner28.
Here we have investigated the pro- and anti-inflammatory res-
ponses of five distinct myeloid cell types: macrophages, neutrophils,
splenic dendritic cells (sDCs), mast cells and eosinophils. Of these,
macrophages, neutrophils, sDCs and mast cells respond to IL-10 by
phosphorylating STAT3 and suppressing pro-inflammatory cyto-
kines. Using genomic technologies we systematically interrogated
the transcriptional changes caused by LPS and IL-10. Macrophages,
sDCs and neutrophils all respond very strongly to LPS, whilst mast
cells and eosinophils showed a weaker response. We show that the
LPS-induced pro-inflammatory transcriptional response is broadly
similar among the myeloid cell types, particularly at the level of
cytokine response. In contrast, the AIR is drastically different across
the four myeloid cell types that respond to IL-10, suggesting that
despite similarity in the myeloid cell phenotype and their response
to LPS, their AIRs are cell type-specific. We further propose models of
the AIR in the distinct cell types and suggest that in macrophages the
AIR is primarily involved in the indirect inhibition of NF-kB signal-
ing, whereas in neutrophils and sDCs the IL-10 response is mediated
by IRFs. Our study brings a new global mechanistic insight into pro-
inflammatory and anti-inflammatory responses in myeloid cells.
Results
The IL-10/STAT3-mediated AIR is activated in macrophages,
neutrophils, sDCs and mast cells, but not in eosinophils. We
explored whether the IL-10 AIR can be activated in five distinct
myeloid cell types, including three primary cell populations
(thioglycollate-elicited peritoneal macrophages, bone marrow
(BM) neutrophils and sDCs) and two BM-derived cell types (mast
cells and eosinophils). Cells were assessed for purity both by
morphology (.80%) and flow cytometry (.90%) (Fig. S1 and see
Materials andMethods). Additionally all cells were treated according
to the same protocol (Fig. 1A), including pre-treatment with IL-10
for 4 h, followed by LPS stimulation for a further 4 h and harvesting.
We decided to focus on these relatively short time periods so as to
minimize secondary effects downstream of either IL-10 or LPS. We
probed STAT3 for Y705 phosphorylation and observed robust
phosphorylation in macrophages, neutrophils, sDCs and mast cells
(Fig. 1B–E, S2), but in eosinophils only a veryweak bandwas observed
(Fig. 1F, S2). Murine eosinophils not showing phosphorylation of
STAT3 is remarkable as human peripheral eosinophils have been
shown to respond to IL-10 by initiating apoptosis and suppressing
GM-CSF, TNFa and IL-8 cytokine production27, although in that case
the IL-10 activity was not specifically linked with STAT3 activation.
Potentially this could be a difference between human peripheral
eosinophils and the mouse BM-derived eosinophils used here, or
may be related to the long-term treatment of eosinophils with IL-10
and LPS as here we only treat the cells for 4 h. Neutrophils were
treated overnight with GM-CSF as a maturation agent29 and most
neutrophils adopted a mature phenotype and additionally showed
IL-10 mediated suppression of Tnf (TNFa) (Fig. S3). Although GM-
CSF has been reported to activate STAT3, at least transiently29, we
could not detect Y705 STAT3phosphorylation after overnight culture
of neutrophils with GM-CSF (Fig. 1B, S2).
Next, to verify that the IL-10-mediated activation of STAT3 in fact
executes an anti-inflammatory response, we quantified the express-
ion changes of a set of inflammatory cytokines. Although the differ-
ent cell types show different magnitudes of response to both LPS and
IL-10 treatment, we can broadly say that macrophages, neutrophils,
sDCs andmast cells present anAIR as determined by the suppression
of Tnfa, Cxcl10 and Il12b upon IL-10 addition (Fig. 1G). As sug-
gested by the lack of STAT3 phosphorylation in eosinophils, sup-
pression of inflammatory cytokines was not observed (Fig. 1G).
Potentially this is due to the low expression of IL-10 receptor genes
Il10ra and IL01rb (Fig. S4A, S4B, S4C, S4D). The lack of STAT3
phosphorylation and corresponding lack of cytokine suppression
indicates that eosinophils do not execute and anti-inflammatory
response.
Principal component analysis reveals cell type-specific expression
profiles and suggests that the pro-inflammatory response has a
cell type-independent component. RNA-seq experiments (Table
S1) were performed to gain a broad picture of the transcriptional
changes associated with the stimulation of all myeloid cell types with
either LPS, IL-10, or both. Analysis of the biological replicates from
independent mice reported Pearson correlations within the range of
0.7–0.9 (with most.0.8), indicating that our RNA-seq libraries are
of high quality (Fig. S5). We performed principal component
analysis (PCA) on all RNA-seq libraries to map the transcriptional
variability of myeloid cells (both resting and stimulated). As
expected, most of the variability arises from the identities of the
various cell types rather than the treatments despite the potent
effect that stimulation with LPS and IL-10 have on gene expression
(Fig. 2A). PC2 through 5 mainly reflected cell type-specific gene
expression programs, whilst a PC corresponding to LPS treatment
did not appear until PC6 (Fig. 2A). At no point could we detect a PC
that corresponded to IL-10 treatment. This indicated to us that the
LPS response had some commonality between the cell types, but the
IL-10 treatment conversely was cell type-specific. Along PC6 the
gene loading indicated many pro-inflammatory factors in common
between the cell responses (Fig. 2B), for example the cytokines Il1a,
Il1b, Tnf (Fig. 2C).
To place ourmyeloid cell RNA-seq libraries into a broader context
we re-analyzed publicly available RNA-seq datasets of related mye-
loid and lymphoid cells and clustered all samples by their pairwise
coefficients of determination (R2). The macrophage and granulocyte
cells cluster with previous RNA-seq samples, and the myeloid cells
are all distinct from lymphoid cells types (Fig. S6).
LPS-induced pro-inflammatory programs are relatively cell type-
invariant.When the distinct types of myeloid cell were treated with
LPS they responded in different ways: whereas all five cell types
upregulate ,1000–2000 transcripts (Fig. 3A; Table S2, S3), the
overall magnitude of activation is much higher in macrophages,
neutrophils and sDCs, whilst eosinophils and mast cells respond
less strongly (Fig. 3B). If we focus only on the three strongest-
responding cells (macrophages, neutrophils and sDCs), 2273
transcripts are upregulated in any 2 of the 3 cell types, indicating a
substantial overlap in the LPS-mediated response, although some
upregulated transcripts remain unique to each cell type (Fig. 3C).
Functional (GO) analysis on the sets of upregulated transcripts
indicates that all five cell types display a robust inflammatory
response, as indicated by enriched GO terms for innate immunity
www.nature.com/scientificreports
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and cytokine production suggesting a strong commonality in the
LPS-mediated pro-inflammatory response (Fig. 3D).
In an alternate approach to the above thresholding strategy we also
used weighted-gene correlation network analysis (WGCNA)30
to correlate genes changes with specific treatments (Fig. S7).
WGCNA identified 1 module specific to LPS-treatment that was
not also significant for any cell-type or IL-10 (Fig S7A). The module
defined 649 genes, of which half were a subset of the genes identified
by thresholding (Fig S7B, C). This alternate approach supports the
idea that the LPS-response is relatively similar across the cell types, in
agreement with the thresholding approach and the appearance of a
principal component (PC6; Fig 2A) that corresponds to LPS
stimulation.
We then analyzed the different families of signaling factors and
looked at changes in gene expression. Cytokine, chemokine and
growth factor gene annotations were manually collated from the
gene ontology terms (e.g. GO:0005125 ‘cytokine activity’) and
divided into 20 ‘families’ (interleukins, chemokines, growth factors
Figure 1 | IL-10 leads to phosphorylation of STAT3 and activates an AIR in macrophages, neutrophils, sDC andmast cells, but not in eosinophils. (A)
Schematic of treatment scheme used in this study. Macrophages, neutrophils, splenic sDC, mast cells and eosinophils were either purified (macrophages,
neutrophils, sDC) or derived (mast cells, eosinophils) frommouse tissues, treated with IL-10 for 4 h and then subsequently treated with LPS for a further
4 hours. Upon addition of IL-10 STAT3 is phosphorylated in neutrophils (B), macrophages (C), sDCs (D) and mast cells (E), but not in eosinophils (F).
Full-length blots are provided in Supplementary Figure 2. (G) qRT-PCR of the pro-inflammatory cytokines Tnf (TNFa), Cxcl10 (IP10) and Il12b, which
are down-regulated when IL-10 is combined with LPS treatment except in eosinophils. Error bars are 95% confidence intervals, significantly down-
regulated (p , 0.05) changes between 1LPS and 1IL-101LPS are indicated. Genes must first be significantly up-regulated by LPS.
www.nature.com/scientificreports
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Figure 2 | Principal componenet analysis of changes in myeloid gene expression. (A) Principal component (PC) analysis of the myeloid cells assayed in
this study. PCs 2 through 7 are indicated, cell types are colored according to the key and where appropriate samples that segregate with and without LPS
are indicated with a line showing the separation and ‘1LPS’ and ‘-LPS’ for the appropriate treatment. At no PC could we detect a gradient that
corresponded to IL-10 treatment. (B) Loading for PC6, which correlates with LPS treatment. (C) Heatmap of the fold-change expression changes of the
top 50 genes at the top of PC6.
www.nature.com/scientificreports
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etc), based on the annotation from the Cytokine Family Database.
Their expression fold-changes upon LPS stimulation showed that the
three families changing most significantly were interleukins, chemo-
kines and TNF (tumor necrosis factor) cytokines (Fig. 3E and Fig.
S8). Indeed, of the cytokines differentially regulated in at least 2 cell
types almost all of them were either interleukins, chemokines or a
TNF-family member, and the strongest responders by fold-change
were consistently chemokines (Fig. 3F). These results suggest sub-
stantial similarity in the LPS response in each of the 5 cells, particu-
larly at the level of cytokine/chemokine activation.
IL-10/STAT3 suppresses distinct subsets of LPS-induced genes in
distinctmyeloid cell types. Inmacrophages the IL-10/STAT3AIR is
known to suppress only a specific subset of all the genes induced by
the LPS pro-inflammatory response31. Therefore the AIR does not
have an indiscriminate effect on transcription, but specifically
inhibits a number of pathways. Since neutrophils, mast cells and
sDCs also respond to IL-10/STAT3, the anti-inflammatory
response best described in macrophages may extend to other
myeloid cells. To investigate this systematically, we divided the
genes that were significantly upregulated by LPS into two classes:
Figure 3 | LPS endotoxin activates a potent, common pro-inflammatory response. (A) The number of transcripts up (left) and down (right)-regulated
by LPS in each cell type and in different combinations of cells. Categories are exclusive, and the total number of genes regulated in the appropriate cell type
is indicated in brackets. (B) Boxplots of relative levels of expression of LPS stimulated genes specifically up-regulated in the respective cell type. (C) Venn
diagrams of up and down regulated transcripts in macrophages, neutrophils and splenic DCs. (D) Gene ontology analysis for up-regulated genes in the
five cell types. (E) Boxplots for all expressed interleukins, chemokines and Tnf-family members. Mann-Whitney-U test: *p-value , 0.05, **p-value ,
0.01. (F) Heatmap of the cytokines/chemokines up-regulated in at least 2 cell types, ordered by overall fold-change of expression upon addition of LPS.
www.nature.com/scientificreports
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(i) ‘AIR genes’, i.e. those that were downregulated at least 2-fold upon
IL-10 stimulation; and (ii) ‘not-AIR genes’, i.e. those whose expression
did not fall by 2-fold. We found that only a subset of transcripts were
downregulated by IL-10 in all myeloid cells investigated here, ranging
from 403 in sDCs (15% of genes) to 759 in neutrophils (34% of genes)
(Fig. 4A;Table S4).Thenumber ofAIR transcripts common to the four
myeloid cell types was surprisingly low (n 5 21), with just 450 AIR
transcripts (28% of all AIR transcripts) down-regulated in any 2 cell
types (Fig. 4B). Compare this to the not-AIR transcripts, which show a
larger agreement, with 2060 (53%) genes common to any 2 cell types
(Fig. 4C). This suggests that the AIR is fundamentally distinct across
the four myeloid cell types. When we looked at the AIR genes from
each cell type and their response in the other four cell types, not only
are the genes very specific to each cell type (as expected since we
removed the set of ‘any 2’ genes from the analysis), but interestingly
we also noticed that theAIR geneswere only stimulated byLPS in their
respective cell type (Fig. 4D; Fig. S9). This indicates that the cell type-
specific component of the LPS pro-inflammatory response is also
suppressed by IL-10 in a cell type-specific manner.
The expression levels of cytokines as an indication of the func-
tional output confirmed that fundamental cell type-specific differ-
ences exist in the mechanism of action of the AIR: whereas
interleukins are the major class of cytokines suppressed in macro-
phages, chemokines are especially suppressed in neutrophils
(Fig. 4E). Looking at the set of AIR genes significantly downregulated
in any 2 or any 3 cell types, the list is clearly dominated by cytokines
and chemokines (Fig. 4F). Collectively our findings indicate that
although macrophages, sDCs, neutrophils and mast cells can exert
an AIR upon stimulation by IL-10, the underlying mechanisms are
divergent across the distinct cell types.
The IL-10/STAT3-mediated AIR employs various mechanisms to
suppress the pro-inflammatory response.Togain additional insights
into the underlying mechanism initiating the pro-inflammatory
response, we investigated the CpG content of the proximal promoters
of AIR and not-AIR genes. Early LPS-responding genes are known to be
CpG-rich, whilst later-responding genes are CpG-poor32. Additionally,
chromatin remodeling at CpG-rich and CpG-poor promoters is known
to be involved in the early and late stages of LPS-mediated gene
activation33. Here we treated the cells with LPS for 4 h and thus
expect the LPS-responding genes to be generally CpG-poor, which is
the case formacrophages (Fig. 5A) andwhen treatedwith IL-10 theAIR
genes show no significant difference in CpG frequency. Conversely
neutrophils, sDCs and mast cells show a significant difference
between AIR and not-AIR genes. Not-AIR genes show CpG levels
similar to the rest of the transcriptome, but conversely AIR genes tend
to be CpG poor. This suggests that in neutrophils, sDCs and mast cells
one of the mechanisms of IL-10-mediated AIR involves CpG islands,
which may reflect an alternate mode of chromatin remodeling33.
LPS stimulation is known to lead to the activation of several tran-
scriptional pathways, particularly IRF3/7, NF-kB and AP-1 (Fos/Jun/
etc)34. To gain some insight into the pathways being activated in the
four cell types we took advantage of a property of TF binding, spe-
cifically that ChIP-seq experiments display a bias for TFs binding
very close to the transcription start site (TSS) of regulated genes35.
Using a collection of TF position weight matrices collated from the
JASPAR, UniPROBE and HT-SELEX datasets36 we scanned the
regions 450 bp upstream and 50 bp downstream from the TSS for
over-represented motifs. We were surprised to observe a stark differ-
ence in the distribution of over-represented TF motifs in AIR and
not-AIR genes (Fig. 5B). In all four cell types, IRF and NF-kB motifs
were overrepresented in either AIR or not-AIR, whilst in sDCs (and
less prominently in neutrophils) an as yet unidentified Zn-finger/
Krueppel TF binding motif was detected among the not-AIR genes.
We did not recover any AP-1 motifs, also thought to be involved in
the TLR mediated transcriptional response34, likely because we ana-
lyzed near the TSS which is already enriched in AP-1 motifs, thereby
highlighting one limitation of this approach. Critically, the over-
represented motifs were unequally distributed amongst the AIR
and not-AIR transcript sets (Fig. 5B; Fig. S10), suggesting that the
AIR works primarily by inhibiting different TF pathways in different
cell types: in macrophages the AIR most likely works through the
inhibition of NF-kB target genes, whilst in sDCs and mast cells it
appears to be through IRF disruption, and in neutrophils it is IRF
inhibition and possibly also indirect NF-kB inhibition.
To explore this idea further, we looked at the down-regulation of
IRF and NF-kB family members, reasoning that although alternate
methods of suppression have been identified, particularly in macro-
phages, one important method is to modulate expression of the
activating TF. In agreement with our model, in neutrophils Irf3,
Irf7 and Nfkb family member transcripts are downregulated by IL-
10, whilst in macrophages IL-10 does not affect the expression levels
of Irf3 and Irf7 (Fig. 5C, 5D). In sDCs and mast cells Irf3 and Irf7
transcripts are down-regulated but NF-kB transcripts remain rela-
tively unaffected (Fig. 5C, 5D). These observations lead us to propose
the model shown in figure 5E, which summarizes the divergent AIR
mechanisms across macrophages, neutrophils, sDCs and mast cells.
IL-10/STAT3 is leading to activation of a diverse set of genes in
myeloid cells.We next looked at the transcripts that were significant
and differentially upregulated by IL-10 after 4 h. The IL-10/STAT3
transcriptional program is divergent in the four cell types with a robust
IL-10 response, showing just 50 genes in common among the three
cell types (Fig. 6A; Table S5), but 39% of the IL-10 up-regulated genes
are common amongst any two cell types, indicating at least some
redundancy in IL-10 signaling, however WGCNA analysis failed to
detect a common module for IL-10 signaling (Fig. S7), suggesting that
the IL-10 signaling pathway is specific to the individual cell types. Of
the 50 genes (60 transcripts) up-regulated in all four cell types
(Fig. 6B), several of the genes we have previously identified as part
of STAT3’s cell type-independent function35,37, suggesting that the
common part of the activation is cell type-independent and that it
likely regulates general aspects of the JAK-STAT signaling pathway.
Indeed, GO/KEGG analysis of the 60 common transcripts returns
only a single significant category: ‘JAK-STAT signaling pathway’
(KEGG:mmu04630, EASE score: 0.0971). Other analysis of gene
ontology indicates many immune process pathways (Fig. 6C), but
nothing specific for each cell type. Many of the genes are also
stimulated by LPS alone (e.g. Fig. 6B), suggesting some degree of
overlap between IL-10 and LPS signaling, something not
unanticipated due to the close relationship between STAT3 and NF-
kB in other biological contexts38. This nevertheless agrees with our
model in Figure 5E: different pathways are being inhibited in the
different types of myeloid cell, thereby underlining the diversity of
the IL-10 response across myeloid cells.
Many known downstream targets of IL-10/STAT3 have been
identified6,39. We noticed that of that list of known targets, only
Bcl3, Socs3 and Sbno2 appear in the up-regulated list in response
to IL-10 in all four cell types (Fig. 6B). Using amore relaxed cut-off of
.1.5 fold induction we collected the known set of genes downstream
of IL-10/STAT3 and marked which of the genes are up-regulated
(Fig. 6D). The IL-10 activity on Nfkbid and Inpp5d are thought to be
post-translational and we see no change in their expression; however
all of the other targets, as expected, are up-regulated in macrophages
(Fig. 6D). Interestingly, of the target genes only a small set are con-
sistently up-regulated in all the cell types surveyed here, suggesting
that known mechanisms of IL-10 action in macrophages may not
immediately extend to other myeloid cell types.
We previously described a cell type-independent mode of STAT3
binding that leads to the activation of a set of genes across cell types as
diverse as macrophages, embryonic stem cells, AtT-20 pituitary cells
and CD41 T cells, and whose role is to fine-tune the JAK-STAT
www.nature.com/scientificreports
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Figure 4 | IL-10 suppression of the LPS-initiated pro-inflammatory response is divergent in the four myeloid cell types. (A) IL-10 suppressed
transcripts (AIR transcripts) were defined as those transcripts declining at least 2 fold. (B) and (C) Transcripts were divided into two categories: (i) AIR
transcripts – those transcripts that decline by at least 2 fold after LPS induction in at least one cell type and (ii) ‘not AIR’ transcripts that did not decline at
least 2-fold after IL-10 treatment. (B) Venn diagram of the IL-10 suppressed genes in the four strongest AIR-responding cell types, macrophages,
neutrophils, sDCs and mast cells. (C) Venn diagram of ‘not-AIR’ transcripts in the four strongest responding cell types. (D) Cell type-specific AIR
transcripts are genuinely cell type-specific. AIR transcripts within the ‘any 2 cell types’ category were removed from the analysis, but no other constraints
were placed. Boxplot outliers are omitted for clarity (See also Fig S9). Mann-Whitney-U test: *p-value , 0.01 between 1LPS and 1IL-10/1LPS
treatments. (E) Box plots showing the changes in gene expression caused by IL-10 on interleukins, chemokines and Tnf familymembers.Mann-Whitney-
U test: *p-value , 0.05 between 1LPS and 1IL-10/1LPS treatments. (F) Heatmap of genes suppressed by IL-10 in at least three cell types.
www.nature.com/scientificreports
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pathway itself independently of the cellular context. When the new
RNA-seq data described in this study was added we continued to see
a consistent up-regulation of these genes (Fig. S11), thereby adding
further support to our model for the cell type-independent binding
mode of STAT335.
Discussion
IL-10 signals through STAT3 to activate a gene expression program
and suppress pro-inflammatory genes31. It is also clear that STAT3
does not act to directly suppress pro-inflammatory genes, as new
protein production is required for the AIR to occur40. Although the
exact mechanism downstream of STAT3 has remained elusive despite
extensive efforts28,31,41,42, in macrophages several genes act downstream
of STAT3, particularly Bcl3, Tnip3, Etv3, Sbno2, Zfp36, Hmox1, Nfil3
and additionally themicroRNAmir1556. These factors inhibit the pro-
inflammatory response by a variety of mechanisms, some by targeting
the inflammatory transcription factor NF-kB directly or by targeting
specific mRNAs post-transcriptionally. Inpp5d (SHIP-1) has been
Figure 5 | LPS and IL-10 employ different mechanisms in distinctmyeloid cells. (A) CpG percent at the promoters of AIR and not-AIR genes. Promoter
is defined as 2450 bp 150 bp around the TSS. The numbers of CG dinucleotides were counted within that window and divided by the number of
promoters in each cell type. The grey dotted line indicates a CpG island frequency of 0.75. Mann-Whitney-U test, **p-value, 0.01. n.s. not significant.
(B) Motif enrichment at the promoters of AIR and not-AIR genes. (C) Changes in expression of Irf family transcripts and Nfkb family transcripts. (D)
Boxplots of changes in Irf and Nfkb family transcripts. (E) A putative model for the differing mechanisms stimulated by LPS and IL-10 in the four cell
types with both a pro and anti-inflammatory response.
www.nature.com/scientificreports
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reported as a target independent of STAT3 signaling43, although
mir155 targets SHIP-1 mRNA for degradation and mir155 is sup-
pressed by IL-10/STAT344, suggesting a STAT3 link. However, no
single factor has yet been able to explain all of the activities of IL-10
upon macrophages4.
Here we set out to determinewhether a conservedAIRmechanism
exists across cells of the myeloid system. Evidence for an AIR exists,
especially inmacrophages and neutrophils, although a full molecular
characterization remains elusive. Here we show that four of the five
myeloid cell types surveyed show evidence of an AIR initiated by IL-
Figure 6 | The IL-10/STAT3 target genes are highly divergent in macrophages, neutrophils, sDCs and mast cells. (A) Venn diagram overlap of genes
significantly differentially regulated by IL-10. (B) Heatmap of the 50 genes (60 transcripts) induced by IL-10 in all four cell types. (C) Gene Ontology
analysis of IL-10 activated genes in macrophages, neutrophils and sDCs. (D) Selected known IL-10/STAT3 target genes implicated in the AIR. The star
indicates a fold-change of at least 1.5 fold in the respective treatment and cell type. Only one Sbno2 transcript is up-regulatedwhilst at the overall gene level
its fold-change is only modestly up-regulated, hence it appears in panel B (transcript analysis).
www.nature.com/scientificreports
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10.Macrophages, neutrophils, sDCs andmast cells all showed robust
STAT3 phosphorylation and transcriptional suppression of cyto-
kines. Curiously, eosinophils did not show strong phosphorylation
of STAT3 nor suppression of inflammatory cytokines, suggesting a
lack of an AIR. Eosinophils derived from human blood do show a
response to IL-10, with increased apoptosis and suppression of TNFa
and IL-1827. This discrepancy could be explained by the difference in
species or cell origin (human peripheral eosinophils versus bone
marrow-derived eosinophils), or could be due to some priming signal
necessary for correct IL-10 activation of eosinophils that ismissing in
our system.
In agreement with results from macrophages31, we also observed
that the IL-10 mediated AIR only suppresses a subset of genes sti-
mulated by LPS.We can now extend that observation to other cells of
the myeloid lineage, where IL-10 leads to the inhibition of between
10–33% of the LPS up-regulated genes. This observation indicates
that whichever mechanism STAT3 uses to suppress pro-inflammatory
genes, it is highly selective and does not inhibit gene expression
globally. Instead the IL-10/STAT3 mechanism seems to inhibit dif-
ferent pathways in different cell types, mainly the inhibition of NF-
kB target genes in macrophages, IRFs in sDCs and mast cells and
both IRF and NF-kB target genes in neutrophils. We should high-
light that these models remain hypothetical and do not immediately
imply a direct action of IL-10 or STAT3 directly on these pathways.
Complex interactions between signaling pathways are a common
observation and in this system STAT3 and NF-kB are antagonistic,
but in other systems STAT3 and NF-kB co-occur and even cause
synergistic gene activation38.
The data set presented here is a fundamental resource for the
exploration of IL-10 and the AIR in other myeloid cell types; the
myeloid cells presented here respond to LPS in relatively similar ways,
but show differences in their AIRs and especially in the genes respond-
ing to IL-10. Thus, the use of the cell type-specific gene expression
signatures could be used to predict likely signaling events in systemic
infection, where the exact activating cell may remain unclear, for
example this technique was used to understand the cell types under-
lying the systemic Crohn’s disease response45, which suggested that the
response of granulocytes and dendritic cells is most important for this
disease. As the transcriptional and epigenetic regulation of gene
expression becomes better understood46 this data set can be used to
model signaling events, including prediction of the complex transcrip-
tional networks controlling the levels of inflammation. Similarly, as
computational techniques become more advanced it may become
possible to predict and even direct cell fate-determining processes
and cell fate conversions. For example, the amalgamation of large
amounts of gene expression data has led to a computational model
to score and design strategies to engineer stem cell differentiation
towards differentiated progeny47. Potentially these techniques could
be applied to expanded immune system cells with much larger sets of
perturbations to model behavior in response to infection and
inflammation.
Our search for a unifiedmechanism of the IL-10/STAT3mediated
AIR in myeloid cells was hampered by the surprisingly low overlap
between the IL-10 suppressed AIR genes across the various myeloid
cell types35. Therefore, the identities of the majority of the effectors
downstream of IL-10/STAT3 in the AIR remain unknown. From this
and previous work we can summarize our knowledge about the path-
ways downstream of IL-10/STAT3: (i) The IL-10/STAT3 mediated
AIR is common to multiple cells of the myeloid system; (ii) IL-10/
STAT3 brings about the specific suppression of a subset of genes in
multiple myeloid cells and not a general suppression; (iii) although
all myeloid cells respond to IL-10, they do so by activating cell type-
specific programs; (iv) it is likely that no single factor downstream of
IL-10/STAT3 exists, instead several pathways may be in action.
Analysis of the genome-wide binding patterns of STAT3 and the
effectors of the LPS-mediated response may shed more light on the
underlying mechanisms, and further work will be required to tease
apart the exact combination of factors required for the AIR across the
diversity of the immune cell repertoire.
Methods
Cell purification and cytokine treatment. Macrophages were extracted by
peritoneal lavage as previously described41. Flow cytometry indicated macrophages
were 83% Mac-11 (Fig. S1A) before being allowed to attach to cell culture plates to
select for adherent cells. Neutrophils were extracted by isolating BM from pooled
mice (at least two mice in each experiment) and purified as described before48 albeit
with somemodifications: briefly, BM cells were first centrifuged through a 72/64/52%
(v/v) Percoll (GE Healthcare) step gradient at 1500 g for 30 min. Next, neutrophils
were collected from the bottom layer of cells and assessed for purity (routinely.80%)
by May-Grunwald-Geimsa staining and 92% Ly6G/Gr-1 positive (Fig. S1B). Typical
contaminants included lymphocytes with very few macrophage-like cells.
Eosinophils were derived according to the protocol described by Dyer et al49: the cells
were harvested and used for experiments on days 12, 14 and 16 and assessed by
morphology and flow cytometry as 90% Siglec F1 (Fig. S1C). Mast cells were derived
according to the protocol described by Jensen et al50: cells were assessed by
morphology as .80% mast cells and were 98% FcREIa1 (Fig. S1D). Splenic DCs
(sDCs) were purified from the spleen using the BD IMag ‘Mouse Dendritic Cell
Enrichment Set –DM’ according to the manufacturer’s instructions. Purified sDCs
were routinely .90% CD11c1 (Fig. S1E). GM-CSF (BioLegend) was used at a final
concentration of 10 ng/ml, IL-10 (R&D Systems) was used at a concentration of
100 ng/ml and LPS (E.coli O55:B5; Sigma-Aldrich) was used at a concentration of
100 ng/ml. At the start of the assay and before treatment with IL-10 or LPS, the
medium was replaced with fresh medium (RPMI1640 with 10% FCS).
Western blots and qRT-PCR.Western blots were performed using typical laboratory
procedures with antibodies to STAT3 (152000, C-20, Santa Cruz), phospho-Tyr705-
STAT3 (151000, D3A7, #9145, Cell Signaling) and GAPDH (1520000, AM4300,
Ambion). qRT-PCR was performed on an ABI7900 using Realtime PCR and SYBR
Green Realtime PCR master mix (TOYOBO). Primers used in this study: TnfF: 59-
TCCAGGCGGTGCCTATGT-39, TnfR: 59-CACCCCGAAGTTCAGTAGACAGA-
39, Cxcl10F: GACGGTCCGCTGCAACTG-39, Cxcl10R: 59-GCTTCCCTATGGC-
CCTCATT-39, Il12bF: 59-ATTGAACTGGCGTTGGAAGCAC-39, Il12bR: 59-TCT-
TGGGCGGGTCTGGTTTG-39, Il10F: 59-GATTTTAATAAGCTCCAAGACC-
AAGGT-39, Il10R: 59-CTTCTATGCAGTTGATGAAGATGTCAA-39.
RNA-seq and computational analysis. RNA from treated peritoneal macrophages,
neutrophils, sDCs, eosinophils and mast cells was harvested with TRIzol (Life
Technologies) according to the manufacturer’s instructions. Biological replicates
were generated from completely independent mice and sequenced on an Illumina
HiSeq 2000. Sequencing andmapping statistics are detailed in table S1. RNA-seq data
was analyzed essentially as described before51. Reads were aligned against ENSEMBL
v67 (mm9) transcripts using RSEM (v1.2.1)52 and bowtie (v0.12.9)53. Raw tag counts
were normalized for GC content using EDASeq (v1.8.0)54. Differential transcript
expression was determined using DESeq (v1.14.0)55. Transcripts were considered as
changing if they were significantly different (q-value, 0.1). Due to the conservative
nature of DESeq and other differential expression algorithms, genes significant in one
cell type were marked as differentially regulated in any other cell type if their fold-
change was.1.5 fold, even if DESeq did not annotate them as significantly different.
This allows a fairer comparison of similarities and differences between the various
treatments. Weighted gene network correlation analysis was performed as
described30. The raw sequence reads were deposited in GEO under the accession
number GSE55385.
Other bioinformatic analyses. The set of transcription factor (TF) genes was
determined by amalgamating into a non-redundant set the predictions from the
DNA-binding Domain database56 and AnimalTFDB57, plus those genes annotated
with the GeneOntology (GO) termGO:0005667 (‘transcription factor complex’). GO
analysis was performed using GOSeq (v1.17.4)58, considering only GO terms
containing between 20–500 genes. PSCAN59 was used for motif enrichment analysis
using our own superlibrary of TF position weight matrices36. Other analyses were
performed using glbase60.
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